Lisa C. Richardson, MD, MPH, is the Director of CDC’s Division of Cancer Prevention and Control (DCPC). She is responsible for providing leadership and direction for all scientific, policy, and programmatic issues related to four national programs: the Colorectal Cancer Control Program, the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries. She oversees a well-developed research agenda that includes the national Cancer Prevention and Control Research Network.
Vicki Benard, PhD, is an epidemiologist with more than 20 years’ experience working in CDC’s Division of Cancer Prevention and Control. In her current position as Chief of the Cancer Surveillance Branch, she leads the National Program of Cancer Registries capturing cancer incidence data from 46 states, the District of Columbia, and 3 territories.
Djenaba A. Joseph, MD, MPH, is board-certified in internal medicine and is a Commander in the Commissioned Corps of the U.S. Public Health Service. She joined CDC as an Epidemic Intelligence Service Officer in the Division of Cancer Prevention and Control from 2005 to 2007, and remained in DCPC as a medical officer.
Jacqueline Miller, MD, FACS, is a board-certified general surgeon and a Captain with the U.S. Public Health Service. She joined CDC as an Epidemic Intelligence Service Officer in the Division of Adult and Community Health. Currently, she is the Medical Director for CDC’s National Breast and Cervical Cancer Early Detection Program.
Mona Saraiya, MD, MPH has worked on issues related to skin cancer epidemiology and cervical cancer prevention and control. Her cervical cancer and human papillomavirus (HPV) research portfolio includes an initiative to characterize the HPV-associated cancer burden in the United States, and adherence to cervical cancer screening guidelines.
Dr. Smith’s research interests include investigating the behavioral, psychosocial, cultural, and system-level factors that impact cancer-related health disparities and cancer survivorship. Dr. Smith is a co-creator of AMIGAS, a bilingual educational intervention designed to increase cervical cancer screening Hispanic women who have rarely or never had a Pap test.
Hannah K. Weir, PhD, MSc, is a senior epidemiologist in the Division of Cancer Prevention and Control’s Epidemiology and Applied Research Branch. Prior to coming to CDC, Dr. Weir was an epidemiologist at Cancer Care Ontario (Canada). Dr. Weir’s research focuses on cancer surveillance, particularly on population-based cancer survival.
Mary C. White, ScD, MFA, has led the development, implementation, and translation of population-based health research at CDC for nearly three decades. In her current position as Chief of the Epidemiology and Applied Research Branch, Dr. White directs a program of applied research and science dissemination to support CDC programs and address national priorities in cancer prevention and control.